IKS Health sees massive growth in US healthcare. The company leverages technology, including AI, to deliver efficient solutions. It aims to expand its market share in the US. IKS Health is also eyeing potential expansion into the Australian and Canadian markets. The company plans to bring its expertise to India in the future.
Tata Motors shares in focus as co hikes prices of commercial vehicles by 2%, effective from Jan 1
Tata Motors will increase truck and bus prices by up to 2% starting January 1, 2025, to offset rising input costs. This follows a recent price hike for its cars and EVs. The company’s Q2 profits and sales declined, though November sales saw a slight increase. Share values have dropped significantly recently.
RIL shares in focus on $12 billion oil deal with Russia’s Rosneft
Reliance Industries secured a massive deal with Rosneft. The deal involves importing Russian crude oil. The agreement spans 10 years. Reliance will receive up to 500,000 barrels of oil daily. This equates to 25 million tonnes annually. The deal is estimated at $12-13 billion. India’s Russian oil imports have significantly increased. Reliance’s Jamnagar refineries will process the crude.
Shriram Finance shares in focus as co sells stake in housing finance biz to Warburg Pincus for Rs 3,929 crore
The stake in Shriram Housing Finance was sold to Warburg Pincus’ affiliate, Mango Crest Investment Ltd. The transaction marks a significant milestone, with all requisite approvals from regulatory authorities and stakeholders duly secured, the company said in its press release on Wednesday.
Cipla shares in focus after receiving CDSCO nod to launch inhalation insulin
Cipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers a non-injectable alternative for managing type 1 and type 2 diabetes. Clinical trials in India demonstrated its effectiveness in reducing HbA1c levels. Cipla aims to improve diabetes management accessibility with this innovative treatment.
Stock Radar: Muthoot Finance breaks out from inverse Head & shoulder pattern; time to buy?
Stocks to buy today: Wipro, L&T among top 9 trading ideas for 11 December 2024
The Indian market is expected to consolidate, with Nifty facing resistance at 24,850 and support at 24,400. Analysts suggest a trading range between 24,200 and 25,000. Several stocks are recommended for short-term trading, including Nippon Life, APL Apollo, and Jindal Steel.
Bullish Momentum: 7 stocks that formed White Marubozu Pattern on December 11
A White Marubozu is a bullish candlestick pattern in technical analysis. It occurs when the opening price is the lowest for a given period and the closing price is the highest.
Market to consolidate for another month, prioritise quality over momentum & value: Sunil Subramaniam
Market expert Sunil Subramaniam analyzes current market trends, citing low consumer spending, government underspending, and FII selling. He anticipates a market consolidation phase for another month, advising investors to prioritize quality stocks and remain patient. Subramaniam predicts increased government spending, improved earnings, and renewed FII interest by mid-January, driven by upcoming elections and budget expectations.
These 6 F&O stocks saw a high increase in futures open interest
This uptrend reflects an increasing number of participants either initiating new positions or expanding the size of their existing positions within the futures market.
